COPD Treatment Landscape Expands, Yet Significant Gaps in Disease Control and Access Persist, According to Spherix Global Insights

Persistent access barriers leave many treatment candidates without advanced therapy as physicians look for stronger disease control and fewer exacerbations.Exton, PA, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Despite recent treatment advances in chronic obstructive pulmonary disease (COPD), physicians continue to report substantial unmet need, particularly among patients with severe disease and a high risk of exacerbations. New research from Spherix Global Insights finds that even among patients receiv